 | | PRD_002231 | | Name: | N~2~-{(4R,7S,10R,13R,16R,19S,24R)-19,24-diamino-16-(3-{[amino(iminio)methyl]amino}propyl)-7-(4-azaniumylbutyl)-10-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18,23-hexaoxo-1,2-dithia-5,8,11,14,17,22-hexaazacyclopentacosane-4-carbonyl}-L-leucinamide | | Formula: | C43 H73 N15 O9 S2 | | Definition date: | 2016-06-01 | | Last modified: | 2016-06-01 |
|
 | | PRD_001260 | | Name: | PAMK PEPTIDE Inhibitor | | Formula: | C48 H80 N12 O15 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002162 | | Name: | N-[(4-carbamimidamidobutyl)carbamoyl]-L-seryl-N-[(2S)-5-{[amino(iminio)methyl]amino}-1-oxopentan-2-yl]-L-valinamide | | Formula: | C20 H41 N10 O5 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002201 | | Name: | (phenylmethyl) ~{N}-[(8~{S},11~{S},14~{S})-8-(hydroxymethyl)-11-(2-methylpropyl)-5,10,13-tris(oxidanylidene)-1,4,9,12,17,18-hexazabicyclo[14.2.1]nonadeca-16(19),17-dien-14-yl]carbamate | | Formula: | C26 H37 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002202 | | Name: | (phenylmethyl) ~{N}-[(9~{S},12~{S},15~{S})-9-(hydroxymethyl)-12-(2-methylpropyl)-6,11,14-tris(oxidanylidene)-1,5,10,13,18,19-hexazabicyclo[15.2.1]icosa-17(20),18-dien-15-yl]carbamate | | Formula: | C27 H39 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002203 | | Name: | (phenylmethyl) ~{N}-[(12~{S},15~{S},18~{S})-15-(cyclohexylmethyl)-12-(hydroxymethyl)-9,14,17-tris(oxidanylidene)-1,8,13,16,21,22-hexazabicyclo[18.2.1]tricosa-20(23),21-dien-18-yl]carbamate | | Formula: | C33 H49 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002230 | | Name: | L-alpha-aspartyl-6-azaniumyl-L-norleucyl-O-phosphono-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-valyl-N-{(3R)-6-{[amino(iminio)methyl]amino}-1-[2-(methoxycarbonyl)-3,5-dimethylphenyl]-2-oxohexan-3-yl}glycinamide | | Formula: | C48 H81 N12 O18 P | | Definition date: | 2016-05-04 | | Last modified: | 2017-12-15 |
|
 | | PRD_002156 | | Name: | N-acetyl-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | | Formula: | C24 H45 N5 O6 | | Definition date: | 2016-03-16 | | Last modified: | 2023-11-03 |
|
 | | PRD_002222 | | Name: | N-(3-bromo-4-methoxybenzene-1-carbonyl)-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C38 H53 Br N7 O11 P | | Definition date: | 2016-02-24 | | Last modified: | 2016-02-24 |
|
 | | PRD_002200 | | Name: | N-benzoyl-L-leucyl-L-leucine | | Formula: | C19 H28 N2 O4 | | Definition date: | 2016-02-17 | | Last modified: | 2016-02-17 |
|
 | | PRD_002217 | | Name: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine | | Formula: | C24 H27 N5 O7 | | Definition date: | 2016-02-03 | | Last modified: | 2016-02-04 |
|
 | | PRD_001259 | | Name: | acyclic trypsin inhibitor | | Formula: | C67 H108 N18 O19 S2 | | Definition date: | 2016-01-13 | | Last modified: | 2016-01-13 |
|
 | | PRD_002208 | | Formula: | C43 H66 N6 O8 | | Definition date: | 2015-12-16 | | Last modified: | 2015-12-16 |
|
 | | PRD_002211 | | Name: | (2~{S})-~{N}-[(1~{R},2~{S})-1-cyano-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-3-phenyl-2-[[(~{E})-3-phenylprop-2-enoyl]amino]propanamide | | Formula: | C27 H30 N4 O4 | | Definition date: | 2015-12-09 | | Last modified: | 2015-12-09 |
|
 | | PRD_000929 | | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-hydroxypropan-2-yl]-L-isoleucinamide | | Formula: | C22 H38 N4 O9 | | Definition date: | 2015-12-02 | | Last modified: | 2015-12-02 |
|
 | | PRD_002214 | | Formula: | C35 H48 N6 O8 | | Definition date: | 2015-12-02 | | Last modified: | 2023-11-03 |
|
 | | PRD_002182 | | Name: | [amino({3-[(3R,6R,9S,12R,15S,21R,24R,27S,30R,33S,36R,39S)-39-amino-36-(4-ammoniobutyl)-12,33-bis(2-carboxyethyl)-30-(4-hydroxybenzyl)-6-[(1S)-1-hydroxyethyl]-3,21-bis(hydroxymethyl)-27-methyl-9,24-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxo-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclodotetracontan-15-yl]propyl}amino)methylidene]ammonium | | Formula: | C63 H106 N18 O21 | | Definition date: | 2015-10-28 | | Last modified: | 2015-10-28 |
|
 | | PRD_000841 | | Name: | CARBOXYPROPYL-BETA-THIOGALACTOSIDE-LYS-PRO-LEUNH2 | | Formula: | C26 H48 N5 O9 S | | Definition date: | 2015-09-16 | | Last modified: | 2015-09-16 |
|
 | | PRD_001241 | | Name: | (BOC)LPA(B27) PEPTIDE | | Formula: | C23 H42 N4 O6 S | | Definition date: | 2015-09-09 | | Last modified: | 2015-09-09 |
|
 | | PRD_002106 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-4-oxo-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C31 H45 N5 O9 S2 | | Definition date: | 2015-07-29 | | Last modified: | 2015-07-29 |
|
 | | PRD_000468 | | Name: | Allosamidin | | Formula: | C25 H42 N4 O14 | | Definition date: | 2015-07-18 | | Last modified: | 2022-03-03 |
|
 | | PRD_002168 | | Name: | N-[(benzyloxy)carbonyl]-O-carbamimidamido-L-homoseryl-N-{(3S,4S)-3-hydroxy-6-methyl-1-oxo-1-[(2-phenylethyl)amino]heptan-4-yl}-L-valinamide | | Formula: | C34 H51 N7 O7 | | Definition date: | 2015-07-15 | | Last modified: | 2015-07-15 |
|
 | | PRD_002103 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-1-{[(1R)-1-carboxybutyl]amino}-2-hydroxy-5-methylhexan-3-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C30 H51 N5 O8 S | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002107 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C31 H47 N5 O8 S2 | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002146 | | Name: | N-[2-(aminomethyl)-5-chlorobenzyl]-1-[(5-methyl-1H-pyrrol-2-yl)carbonyl]-L-prolinamide | | Formula: | C19 H23 Cl N4 O2 | | Definition date: | 2015-06-17 | | Last modified: | 2015-06-17 |
|
